2025 Expert Speakers

For full session details, explore the program:

VIEW THE PROGRAM
Alexandra Haugh, Medical Oncologist, Massachusetts General Hospital and Harvard Medical School

Alexandra Haugh

Medical Oncologist

Massachusetts General Hospital and Harvard Medical School

Andrew Weinburg, Chief Executive Officer, AgonOx

Andrew Weinberg

Chief Executive Officer

AgonOx

Anna Truppel Hartmann, Chief Medical Officer, KSQ Therapeutics

Anna Truppel-Hartmann

Chief Medical Officer

KSQ Therapeutics

Arnaud Foussat, Chief Executive Officer, Carmil Therapeutics

Arnaud Foussat

Chief Executive Officer

Carmil Therapeutics

Cecilia Zhang, Chief Scientific Officer, Biosyngen

Cecilia Zhang

Chief Scientific Officer

Biosyngen

Divya LenkalaFormer Group Leader, T-Cell Immunology, BioNTech

Divya Lenkala

Former Group Leader, T-Cell Immunology

BioNTech

Eric Chen, Founder & Chief Executive Officer, Achelois BioPharma

Eric Chen

Founder & Chief Executive Officer

Achelois BioPharma

Inge Jedema, Head of Translational Cellular Therapy, The Netherlands Cancer Institute

Inge Jedema

Head of Translational Cellular Therapy

The Netherlands Cancer Institute

James Smithy, Assistant Attending Physician, Memorial Sloan Kettering Cancer Center

James Smithy

Assistant Attending Physician

Memorial Sloan Kettering Cancer Center

Jingwei Sun, Vice President, Research & Development, Grit Biotechnology

Jingwei Sun

Vice President, Research & Development

Grit Biotechnology

Lindsay Held, TIL Therapy Patient & Patient Advocate, Independent Patient Advocate

Lindsay Held

TIL Therapy Patient & Patient Advocate

Independent Patient Advocate

Lucas Arruda, Chief Scientific Officer, CuraCell

Lucas Arruda

Chief Scientific Officer

CuraCell Holding AB

Madan Jagasia, Chief Executive Officer, Obsidian Therapeutics

Madan Jagasia

Chief Executive Officer

Obsidian Therapeutics

Marcus Butler, Clinician Investigator, University Health Network

Marcus Butler

Clinician Investigator

University Health Network

Mario Kuttke, Head of Cell Therapy, invIOs

Mario Kuttke

Head of Cell Therapy

invIOs

Markus Maeurer, Professor, Champalimaud Foundation

Markus Maeurer

Professor

Champalimaud Foundation

Micah Benson, Chief Scientific Officer, KSQ Therapeutics

Micah Benson

Chief Scientific Officer

KSQ Therapeutics

Michael Lotze, Professor - Department of Surgery, Immunology, Bioengineering, University of Pittsburgh Department of Medicine

Michael Lotze

Professor - Department of Surgery, Immunology, Bioengineering

University of Pittsburgh Department of Medicine

Nicholas Restifo, Chief Medical Officer, Medici Therapeutics

Nicholas Restifo

Chief Medical Officer

Medici Therapeutics

Parameswaran Hari, Chief Development Officer, Obsidian Therapeutics

Parameswaran Hari

Chief Development Officer

Obsidian Therapeutics

Pierpaolo Ginefra, Senior Scientist, Ludwig Institute for Cancer Research

Pierpaolo Ginefra

Senior Scientist

Ludwig Institute for Cancer Research

Pin Wang, Chief Scientific Officer, Grit Biotechnology

Pin Wang

Professor

Grit Biotechnology

Roda Amaria, Professor, MD Anderson Cancer Center

Roda Amaria

Professor

MD Anderson Cancer Center

Yi Zhao, Chief Executive Officer, Sino Cell Biomed

Yi Zhao

Chief Executive Officer

Sino Cell Biomed

"The summit gathered people working in the TIL field and made close interaction and deep communication possible."

Vice President of R&D, Grit Biotechnology - 2024 Speaker

VIEW THE PROGRAM
REGISTER
PARTNER OPPORTUNITIES